The opportunity
Synchron makes the Stentrode, an endovascular BCI delivered through the jugular instead of open-skull surgery. Patients have used it to control devices by thought in clinical studies, first human patients are already online. Paralysis is the near-term use; a BCI that threads a blood vessel is how you get past the OR bottleneck. Skull implants stay rare because the surgery is the product risk. A stent-based interface with human data is scarce. The equity story is the less-invasive path while the category is still private.
Proof of ownership publishedFrom $20Peer-to-peer bids and offers
Valuations explained
WLTH entry
$1.01B
The valuation of the private round where WLTH secured this allocation. New Slices issued from this raise are priced from this entry.
In-app
The lowest implied valuation from live Slice listings on the WLTH marketplace. It moves with what holders are asking, not with a new company round.
Company valuation
$1.01B
The company’s latest reported valuation (last private round, or live market cap after IPO). This is the headline number, not what you pay on WLTH.
Private-market investment. Capital is at risk and values can fall as well as rise. This is not investment advice.
Deal terms
WLTH entry
$1.01B
Company valuation
$1.01B
Structure
Slice
Liquidity
Marketplace
WLTH growth
$ 1.01B → $ 1.01B
0%
1:1
Each Slice is backed 1:1 by underlying equity in this company.
Synchron pre-IPO deal overview
Get in before the IPO. Back the brain-computer interface that threads a Stentrode through blood vessels, not open-skull surgery.
Available
The opportunity
Synchron makes the Stentrode, an endovascular BCI delivered through the jugular instead of open-skull surgery. Patients have used it to control devices by thought in clinical studies, first human patients are already online. Paralysis is the near-term use; a BCI that threads a blood vessel is how you get past the OR bottleneck. Skull implants stay rare because the surgery is the product risk. A stent-based interface with human data is scarce. The equity story is the less-invasive path while the category is still private.
Proof of ownership publishedFrom $20Peer-to-peer bids and offers
Valuations explained
WLTH entry
$1.01B
The valuation of the private round where WLTH secured this allocation. New Slices issued from this raise are priced from this entry.
In-app
The lowest implied valuation from live Slice listings on the WLTH marketplace. It moves with what holders are asking, not with a new company round.
Company valuation
$1.01B
The company’s latest reported valuation (last private round, or live market cap after IPO). This is the headline number, not what you pay on WLTH.
Private-market investment. Capital is at risk and values can fall as well as rise. This is not investment advice.
Deal terms
WLTH entry
$1.01B
Company valuation
$1.01B
Structure
Slice
Liquidity
Marketplace
WLTH growth
$ 1.01B → $ 1.01B
0%
1:1
Each Slice is backed 1:1 by underlying equity in this company.
Synchron in the news
Latest coverage and WLTH writing about this company.
What you’re actually buying
Pre-IPO means investing before a company lists publicly, when access is usually locked to insiders. Here's how WLTH opens it up.
A private round
Synchron raised capital at a ~$1.01B company valuation, long before any IPO.
WLTH gets an allocation
WLTH secures a slice of that round, normally reserved for large institutions.
You own a Slice
You get tokenized economic exposure to the underlying asset backed 1:1 and verifiable. Self custodied and tradable at any time.
No paperwork, no five-figure minimums. Own a Slice from $20, with payouts in USDC.
Frequently asked questions
What is a WLTH Slice?
A tokenized position backed 1:1 by real underlying equity in the company, not a synthetic price tracker.
What's the minimum?
You can invest from $20. Available to eligible users outside the US and UK.
Can I sell before an IPO?
You may be able to list your Slice on the WLTH marketplace, subject to terms and demand. Liquidity is not guaranteed.
How is my Slice backed?
Your Slice is a contractual economic right tied to a WLTH allocation. Review the fund offering documents for structure and risks.
What is Synchron on WLTH?
Synchron on WLTH is fractional, tokenized pre-IPO exposure backed by equity in the underlying private company. Investors buy slices from published valuations, track diligence in the app, and may trade on the WLTH Marketplace after listing. Minimums and availability depend on the live fund.
Available
Invest in Synchron pre-IPO on WLTH
Get in before the IPO. Back the brain-computer interface that threads a Stentrode through blood vessels, not open-skull surgery.
WLTH entry
$1.01B
Company valuation
$1.01B
Synchron investors include
The opportunity
Synchron makes the Stentrode, an endovascular BCI delivered through the jugular instead of open-skull surgery. Patients have used it to control devices by thought in clinical studies, first human patients are already online. Paralysis is the near-term use; a BCI that threads a blood vessel is how you get past the OR bottleneck. Skull implants stay rare because the surgery is the product risk. A stent-based interface with human data is scarce. The equity story is the less-invasive path while the category is still private.
Proof of ownership publishedFrom $20Peer-to-peer bids and offers
Valuations explained
WLTH entry
$1.01B
The valuation of the private round where WLTH secured this allocation. New Slices issued from this raise are priced from this entry.
In-app
The lowest implied valuation from live Slice listings on the WLTH marketplace. It moves with what holders are asking, not with a new company round.
Company valuation
$1.01B
The company’s latest reported valuation (last private round, or live market cap after IPO). This is the headline number, not what you pay on WLTH.
Private-market investment. Capital is at risk and values can fall as well as rise. This is not investment advice.
Deal terms
WLTH entry
$1.01B
Company valuation
$1.01B
Structure
Slice
Liquidity
Marketplace
WLTH growth
$ 1.01B → $ 1.01B
0%
1:1
Each Slice is backed 1:1 by underlying equity in this company.
Synchron in the news
Latest coverage and WLTH writing about this company.
What you’re actually buying
Pre-IPO means investing before a company lists publicly, when access is usually locked to insiders. Here's how WLTH opens it up.
A private round
Synchron raised capital at a ~$1.01B company valuation, long before any IPO.
WLTH gets an allocation
WLTH secures a slice of that round, normally reserved for large institutions.
You own a Slice
You get tokenized economic exposure to the underlying asset backed 1:1 and verifiable. Self custodied and tradable at any time.
No paperwork, no five-figure minimums. Own a Slice from $20, with payouts in USDC.
Frequently asked questions
What is a WLTH Slice?
A tokenized position backed 1:1 by real underlying equity in the company, not a synthetic price tracker.
What's the minimum?
You can invest from $20. Available to eligible users outside the US and UK.
Can I sell before an IPO?
You may be able to list your Slice on the WLTH marketplace, subject to terms and demand. Liquidity is not guaranteed.
How is my Slice backed?
Your Slice is a contractual economic right tied to a WLTH allocation. Review the fund offering documents for structure and risks.
What is Synchron on WLTH?
Synchron on WLTH is fractional, tokenized pre-IPO exposure backed by equity in the underlying private company. Investors buy slices from published valuations, track diligence in the app, and may trade on the WLTH Marketplace after listing. Minimums and availability depend on the live fund.